Introduction
The protein components of complement (C) are activated through proteolysis in a cascade-like fashion (by pathways known as the classical, alternative or lectin), leading to the generation of activated/cleaved proteins that bind to the C-activating surface and small liquid-phase activation peptides with potent proinflammatory properties that have been termed anaphylatoxins. 1, 2 Two groups of C3 cleavage fragments are distinguished -fluid phase (C3a, C3a des-Arg ) and cell-or extracellular matrix-bound (C3b, iC3b, C3dg, C3d) fragments. 3 C3a and C3b are the first cleavage products of C3 and each has a short half-life in plasma. C3a is processed by serum carboxypeptidase N (SCPN) to C3a des-Arg (long half-life cleavage product), and C3b is cleaved into iC3b (long half-life cleavage product) by factor I. 3, 4 The C3dg and C3d fragments (very long half-life) are generated from substrate-bound iC3b by proteolysis with various proteolytic enzymes including factor I, plasmin, and leukocyte elastase.
C3 cleavage fragments bind to several specific C3 receptors. 5 While C3a binds to G-protein-coupled, seven transmembranespanning C3aR and C5L2, C3a des-Arg binds only to C5L2. [6] [7] [8] The receptor for iC3b, CR3, is the a M b 2 -integrin, known also as CD11b/CD18 or Mac-1. [9] [10] [11] [12] The classical C3a receptor, C3aR, is predominantly expressed on the surface of human mast cells, eosinophils, monocytes, and activated T lymphocytes. 5, [13] [14] [15] [16] Its major functions include chemotaxis of eosinophils and the recruitment and degranulation of mast cells. CR3 is expressed on granulocytes, monocytes/macrophages, and NK cells, 5 and has been shown to be expressed on a significant proportion of HSPC. 17 Recently, we showed that a functional C3aR is also expressed by normal human HSPC and lineage-expanded hematopoietic precursors, and its activation sensitizes the responses of these cells to the a-chemokine stromal-derived factor (SDF)-1. 18 This C3aR-mediated signaling influenced the homing of HSPC to the bone marrow (BM) by promoting their (i) chemotactic response to SDF-1, (ii) adhesion to VCAM-1 mediated by SDF-1, (iii) expression/secretion of MMP-9, and (iv) SDF-1-dependent migration across subendothelial basement membranes. C3a priming of Sca-1 þ cells was also shown to accelerate their engraftment in lethally irradiated mice. 18 Hence, it was concluded that the C3a-C3aR axis modulated responses dependent upon the SDF-1-CXCR4 axis, thereby regulating the homing of HSPC into BM. 18 The SDF-1-CXCR4 axis plays a pivotal role in homing/ retention of hematopoietic stem cells (HSC) in BM. [19] [20] [21] [22] [23] [24] [25] [26] It has been recently demonstrated that CXCR4 requires an association with membrane lipid rafts for proper signaling function. 27, 28 These membrane domains are rich in sphingolipids and cholesterol, which form a lateral assembly in a saturated glycerophospholipid environment. 29 The raft domains are known to serve as moving platforms on the cell surface, and are more ordered and resistant to nonionic detergents than are other areas of membranes. These domains also act as good sites for crosstalk between various cellular proteins. It has been recently reported that small GTPases such as Rac-1 and Rac-2, that are crucial for engraftment of hematopoietic cells after transplantation, are present in the lipid rafts of migrating cells. [30] [31] [32] [33] Lipid rafts have been shown to be important for T-cell polarization and chemotaxis. 30, 34 To learn more about the role of C3 in HSC engraftment, this study employed C3 À/À mice and their WT littermates as a model. Since it was observed that these mice had a defect in hematopoietic recovery after transplantation, it was of interest to determine if the C3 cleavage fragments C3a, C3a des-Arg and iC3b modulated the engraftment and homing of HSPC in BM. Our data suggest that C3 plays an important and hitherto unrecognized role in this process.
Materials and methods

Murine and human BM-derived cells
Murine BM mononuclear cells (BMMNC) were flushed from the femora of C57B1/6 C3 À/À and WT C57Bl/6 C3 þ / þ mice (breeders purchased from The Jackson Laboratory, Bar Harbor, ME, and used to establish a colony at the Brown Cancer Center 18, 37, 38 The purity of isolated BM CD34 þ cells was 495%, as determined by fluorescence-activated cell sorter (FACS) analysis using a FACscan (Becton Dickinson, San Jose, CA, USA).
In some experiments BMNC were obtained from CR3 À/À and C3aR À/À mice, and their Sca-1 þ cells were isolated as described above. Adherent cells were expanded to grow BM stroma for adhesion assays as described.
39-41
Chemotaxis assays
Medium containing either no chemoattractant or C3a (1 mg/ml), C3a des-Arg (1 mg/ml) (Callbiochem Inc.), SDF-1 (low dose: 10 ng/ ml, high dose: 300 ng/ml; R&D Systems, Minneapolis, MN, USA) or combinations of the above were added to the lower chambers of a Costar Transwell 24-well plate (Costar Corning, Cambridge, MA, USA). Aliquots of a cell suspension were loaded into the upper chambers, and the cultures were incubated (371C, 95% humidity, 5% CO 2 ) for 3 h, after which the cells in the lower chamber were scored using FACS analysis. The results are presented as a chemotactic index (ratio of the number of cells that migrated towards the medium with SDF-1 to the number of cells that migrated towards medium alone). Chemotaxis was also performed toward conditioned medium (CM) isolated from BMMNC taken from 900 cGy total body irradiated (TBI) C3 À/À and WT mice. In some of the experiments, the directional migration to CM harvested from these cells was performed on cells preincubated for 30 min at 371C in the presence of 1 mM T140-truncated polyphemusin analog (a CXCR4 antagonist that was a gift from Dr Nobutaka Fuji, Kyoto University, Japan). 41, 42 To evaluate the influence of lipid raft formation on chemotaxis, the cells used in some experiments were incubated before the chemotaxis assay in medium containing 2.5 mM of methylo b-cyclodextran, 25 mg/ml Nystatin, or 5 mg/ml of amphotericin-B (Sigma, St Louis, MO, USA), as described. 27, 43, 44 
Confocal analysis
For visualization of lipid rafts, human myelomonocytic THP-1 cells (ATCC, Rockville, MD, USA) were fixed in 3.7% paraformaldehyde/Ca-and Mg-free PBS for 15 min, and permeabilized with 1% Triton X-100 in PBS for 5 min at RT.
The primary reagents used for raft analysis were cholera toxin Bsubunit conjugated with FITC (Sigma Aldrich, St Louis, MO, USA) and mouse monoclonal anti-hCXCR4 IgG (R&D Systems). After being rinsed in PBS, the sections were incubated with Alexa Fluor 568 goat anti-mouse IgG (Molecular Probes, Eugene, OR, USA) for 45 min. The stained cells were examined using a BX51 fluorescence microscope equipped with a chargecoupled device camera (Olympus America, Melville, NY, USA). Separate pictures were merged using Image-Pro Plus software (Media Cybernetics, Inc., Silver Spring, MD, USA). Each staining was repeated three times on separate samples.
Isolation of lipid rafts
THP-1 cells (5 Â 10 7 ) were lysed in 300 ml of MEB buffer (150 mM NaCl, 20 mM MES, pH 6.5) containing 1% Triton X-100 and protease inhibitors (500 mM PMSF and 5 mM iodoacetamide) for 1 h on ice. The cells were mixed with an equal volume of 80% sucrose in MEB and placed at the bottom of a centrifuge tube. The samples were overlaid with 30 and 5% sucrose in MEB and centrifuged at 100 000 g for 17 h. Fractions were gently removed from the top of the gradient and n-octylglucoside was added to each fraction (60 mM final) to dissolve the rafts. To detect in lipid rafts the presence of both CXCR4 and ganglioside GM1 (a marker of lipid rafts), Western blot analysis was carried out using standard techniques with anti-hCXCR4 antibody (Serotec, Oxford, UK) and cholera toxin subunit B/HRPconjugate (Sigma), that bind to CXCR4 and GM1, respectively.
27,43,44
BM transplantation
For transplantation experiments, mice were irradiated with a lethal dose of g-irradiation (900 cGy). After 24 h, the mice were transplanted (by tail vein injection) with 10 6 of BMMNC or 10 5 BM MNC Sca-1 þ cells. Transplanted mice were bled at various intervals from the retro-orbital plexus to obtain samples for leukocyte, platelet, and hematocrit counts as described.
18,37
Evaluation of engraftment CFU-S assay: For the colony-forming units-spleen (CFU-S) assays, mice were transplanted with 5 Â 10 4 Sca-1 þ marrow cells. At day 12, spleens were removed, fixed, and CFU-S colonies were counted on the surface of the spleen.
Number of cells/femur: Femora of transplanted mice were flushed with PBS at day 16 post-transplant and the number of MNC were counted 18, 37 Clonogenic assays: Sca-1 þ cells were isolated from transplanted animals at day 16 after transplantation. Cells were plated in serum-free methylcellulose cultures and stimulated to grow CFU-GM colonies by G-CSF þ IL-3.
Statistical analysis
Arithmetic means and standard deviations were calculated using Instat 1.14 (Graphpad, San Diego, CA, USA) software. Data were analyzed using Student's t-test for unpaired samples and statistical significance was defined as Po0.01.
Results
C3
À/À mice show a defect in hematopoietic recovery following either sublethal irradiation or transplantation of WT HSPC Since C3 is activated/cleaved in irradiated BM (eg, during conditioning for transplantation by chemotherapy or irradiation, 45 and mobilization, 38 ) and, in addition, both the C3aR and the iC3b-receptor CR3 are expressed by HSPC, 11, 12, 17, 18, 46, 47 this investigation focused on whether C3 À/À mice had any type of hematological abnormalities. First, it was confirmed that these mice, under normal steady-state conditions, do not have any significant abnormalities in peripheral blood parameters. Nevertheless, they exhibited a significant delay in recovery of hematopoiesis after sublethal irradiation or after transplantation of syngeneic WT BM cells. 
Chemotactic response of HSPC to BM supernatants from C3
À/À and WT littermates
The defect of engraftment of WT HSC in C3 À/À mice and normal engraftment of HSC from C3 À/À mice in WT animals show that HSPC from C3 À/À mice are normal and that the observed defect is related primarily to an environmental dysfunction in the BM of these animals.
To address this issue better, cells were isolated from BM of C3 À/À and WT animals at 24 h after 900 cGy total body irradiation (TBI) and the cells were incubated in a small volume of culture medium (400 ml/10 7 cells) for 1 h at 371C. Next, the CM from these cells were collected and tested in chemotactic assays for their ability to attract WT Sca-1 þ cells. The cells recovered after chemotaxis from the lower transwell chambers were harvested and plated in methylcellulose cultures to evaluate the number of CFU-GM progenitors that were chemoattracted by CM. Table 1 shows that CM from marrow cells from TBIconditioned C3
À/À mice were less effective in chemoattracting CFU-GM progenitors as compared to CM harvested from WT BM cells. Furthermore, since chemotaxis to CM derived from irradiated WT and C3 À/À BM cells was inhibited after exposure The number of CFU-GM from Sca-1 + wt cells that were chemoattracted to culture medium (CM) from BM cells obtained from irradiated WT mice was arbitrarily assumed to be 100%. Data are pooled from quadruplicate samples from three independent experiments (n ¼ 12). *Po0.00001.
of Sca-1 þ cells to the CXCR4 antagonist, T140, 41, 48 it is likely that SDF-1 was the major chemoattractant in this assay.
Analysis of the defect in chemoattraction of HSPC by CM from C3
À/À BM cells
To determine if the differences in chemoattraction of WT HSPC between CM derived from C3 À/À mice vs WT BM cells could be explained by differences in SDF-1 expression in BM stroma cells that survived TBI, real time RT-PCR was performed to compare differences in expression of mRNA for SDF-1. However, no differences were found. Furthermore, a comparable level of SDF-1 protein expression was shown by ELISA in CM harvested from both types of cells (not shown).
It was recently reported that C3a enhances the chemotactic reponses of HSPC to an SDF-1 gradient. 18 To determine if the differences in chemoattraction of BM cells by CM from WT vs C3 À/À stroma were related to a lack of C3 cleavage fragments in the CM, 1.0 mg/ml of C3a was added to the CM prior to the chemotaxis assay. The added C3a restored the chemotactic response of CFU-GM cells to CM from C3 À/À BM cells to a level comparable to that observed with the CM from WT mice (Table 1) . Thus, the data suggested that an absence of C3a in the CM generated from the BM of irradiated C3 À/À mice was responsible for the diminished chemotactic response of WT Sca-1 þ cells. Unexpectedly, a similar effect was also observed when the CM from irradiated C3 À/À BM was supplemented with C3a des-Arg , a derivative of C3a which is inactive with classical C3aR (Table 1 ). This suggested that both C3a and C3a des-Arg could modulate the responsiveness of HSPC to an SDF-1 gradient. Since C3a has a very short half-life, it was hypothesized that the added function of the long-lived C3a des-Arg derivative resulted in a 'prolonged' biological activity of C3a.
Evidence of C5L2 receptor involvement in engraftment of HSPC
The data presented above suggested that a defect of engraftment in C3
À/À mice could be explained by a lack of C3a and its ability to sensitize HSPC responses to SDF-1 gradients. To characterize further the involvement of the C3aR in engraftment of HSPC, WT mice were transplanted with Sca-1 þ cells isolated from C3aR À/À or WT Balb/c mice. However, no differences were observed in either the recovery of hematopoietic parameters or CFU-S colony formation between mice transplanted with C3aR À/À or WT HSPC (not shown). Since the responses of WT Sca-1 þ cells to an SDF-1 gradient were primed by either C3a or C3a des-Arg , and C3a des-Arg does not stimulate the classical C3aR, 4 these data in toto suggested that another type of C3a receptor (ie, C5L2 that binds to both C3a and C3a des-Arg ) 6,7,49 might compensate for a deficiency of C3aR in HSPC homing responses. To investigate whether both C3a and C3a des-Arg could function to prime HSPC via C5L2, the chemotactic responses of Sca-1 þ cells from C3aR À/À and WT mice to SDF-1 were tested in the presence or absence of C3a. Figure 2 , panel a shows that cells from both C3aR
À/À and WT mice were similarly primed by C3a for chemotactic responses to an SDF-1 gradient. These data further suggested the involvement of C5L2, and support the hypothesis that the observed priming effect on SDF-1 responses may be mediated in C3aR À/À HSPC via activation of C5L2. RT-PCR assays confirmed that mRNA for this receptor was expressed on both murine Sca-1 þ and human CD34 þ BMMNC cells ( Figure 2, panel B) . This observation, however, has to be confirmed in the future when the appropriate antibodies against C5L2 receptor, C5L2 knockout animals or C5L2 antagonists become available. The role of the C3a des-Arg -C5L2 axis in priming responses to a SDF-1 gradient was further implicated by showing that C3a des-Arg primed human CD34 þ cells to an SDF-1 gradient. Moreover, this enhancing effect was not inhibited by the C3aR antagonist, SB290042 (Calbiochem, San Diego, CA, USA) (not shown). These functional assays, along with the RT-PCR data, suggest that CD34 þ cells have functional C5L2 receptors on their surface, allowing C3a des-Arg to function similarly as C3a in modulating their homing properties.
C3a and C3a des-Arg increase the incorporation of CXCR4 into membrane lipid rafts
With several receptor classes, incorporation of the receptors into lipid rafts increases signaling efficiency, 34, 50, 51 and thus, if CXCR4 would be incorporated into rafts during priming with C3a, then it might be able to signal with lower concentrations of SDF-1. Accordingly, the hypothesis that the priming effect of C3a and C3a des-Arg was dependent on membrane lipid raft formation was investigated.
To address this question, chemotaxis assays to low doses of SDF-1 were performed with unprimed or C3a/C3a des-Arg primed CD34 þ cells, with or without additional treatment with 2.5 mM hydoxypropyl-b-cyclodextrin (MBCD) (Sigma, St Louis, MO, USA), an agent that functions to perturb lipid raft formation by extracting membrane cholesterol (Figure 3a) . These studies showed that the priming effect of C3a and C3a des-Arg on SDF-1
Figure 2
Sca-1 þ cells from C3aR À/À mice are primed to SDF-1 in a C5L2-dependent manner. Panel (a) -Chemotaxis of normal murine BMMNC Sca-1 þ cells derived from C3aR À/À (black bars) and WT (white bars) mice was evaluated toward medium alone (control), SDF-1 low dose (10 ng/ml), C3a alone (1 mg/ml), SDF-1 low dose with cells exposed to C3a (1 mg/ml) or SDF-1 optimal high dose (300 ng/ml). Data are pooled from quadruplicate samples analyzed in three independent experiments. The role of the third complement component in engraftment of HSPC MZ Ratajczak et al chemotaxis was blocked by this raft-disrupting agent, whereas the chemotactic response to SDF-1 alone was unaffected.
To provide more evidence that the priming effect of these small C3 fragments depended on lipid raft formation, confocallike ( Figure 3b ) and Western blot analysis ( Figure 4) were carried out to assess CXCR4 incorporation into membrane lipid rafts in monocytic THP-1 cells primed by C3a and C3a des-Arg . As expected ( Figure 3, panel b; Figure 4 , panel a), CXCR4 in THP-1 cells stimulated by C3a and C3a des-Arg became incorporated into cell membrane lipid rafts.
Tethering of CR3
þ HSPC to iC3b deposited onto BM stroma
The other stable C3 fragment generated by C3 activation is the large iC3b fragment, which is deposited onto C-activating surfaces. Previous studies had shown that iC3b was deposited onto BM stroma damaged by G-CSF mobilization or gamma radiation, 38, 45 and further that HSPC expressed the iC3b-receptor CR3. 11, 12, 17, 46, 47 To determine if such solid-phase iC3b deposited onto BM stroma also played a critical role in BM recovery, experiments were carried out to explore the role of HSPC CR3 in tethering HSPC to sites of BM damage marked by deposited iC3b.
In these experiments, Sca-1 þ cells from WT and CR3 À/À mice were tested for adhesion to iC3b deposited in vitro onto cultured BM stroma cells. BM stroma cells from C3 À/À mice (to exclude the potential contribution by C3 produced by stroma cells themselves) were g-irradiated (to express a neoepitope recognized by an IgM antibody present in normal serum) and subsequently exposed to serum (source of IgM and C3) from WT or C3 À/À mice. The deposition of iC3b was confirmed by FACS using an affinity-purified goat anti-mouse C3 Ab-Oregon Green on the surface of stroma cells that were exposed to WT serum only. For adhesion assays, Sca-1 þ cells were employed from WT or CR3 À/À mice. After 1 and 6 h of adhesion, nonadherent cells were discarded from the adhesion cultures and the cells in the wells were trypsinized and subsequently plated in methylocellulose cultures stimulated to grow CFU-GM colonies. Since marrow fibroblasts were irradiated before the adhesion assay, they did not grow after plating in methylcellulose. Table 2 shows that, after 1 h of adhesion, CFU-GM were tethered to stroma cells in a CR3-iC3b-dependent manner. In prolonged adhesion (6 h), this effect was not visible, suggesting that this interaction is important in early adhesion and may be compensated later on by other adhesion molecules. Thus in addition to the C3a-C3aR and C3a des-Arg -C5L2 axes, the CR3-iC3b axis may play an important role in the retention of HSPC in BM and thus contribute to marrow reconstitution from irradiation.
Discussion
Evidence has been accumulated that C3 plays an important, and until now, underappreciated role in the retention of HSPC in 
Figure 4
Western blot analysis of CXCR4 in various cell membrane fractions enriched in lipid rafts (fractions 3-5) or depleted of lipid rafts (fractions 9-11). Panel (a) -THP-1 cells were stimulated with C3a (1 mg/ml) or C3a des-Arg (1 mg/ml) or not stimulated (control). CXCR4 and Rca-1 were detected in these membrane fractions by Western blot along with ganglioside GM1, a marker of lipid rafts. Experiments were performed three times with similar results. Panel (b) -In control experiments, the cells were pretreated for 1 h with 10 mM MBCD. A representative study is shown.
BM. Studies reported over 20 years ago first showed that depletion of C in mice with cobra venom (CoF), which lowered serum C3 levels to 10-25% of normal values, completely prevented CFU-S mobilization induced by endotoxin. 52 Our recent report demonstrated that mice deficient in either C3 or C3aR were more sensitive to mobilization by G-CSF than were WT mice, and that mobilization in WT animals could be increased by employing a C3aR antagonist. 38 Moreover, an anti-CR3 mAb has been reported to enhance mobilization in mice, suggesting an involvement of the iC3b-CR3 axis in addition to the C3a-C3aR axis. 47 The C system, which is a major inflammatory mediator, is also a normal physiological constituent of the BM environment. Not only have human BM stroma fibroblasts been shown to secrete C3, 18 but also BM macrophages are known to synthesize and secrete all C components. 53, 54 Our initial research demonstrated that C is activated and C3 becomes activated in BM after conditioning for hematopoietic transplant by TBI or chemotherapy, or after G-CSF mobilization. 45 The proteolytic activation of C3 generates the small fluid-phase activation peptide C3a and a larger C3b fragment that becomes bound to the C-activating surface. The C3a is rapidly converted to C3a des-Arg by serum carboxypeptidase N, whereas the BM stroma-and extracellular matrix-bound C3b is rapidly degraded into iC3b by the serum protease factor I. 3 Thus, activation of C3 in the BM environment results in the generation of both fluid-phase short-lived C3a and long-lived C3a des-Arg , as well as solid-phase short-lived C3b and long-lived iC3b.
This report demonstrates that trafficking of HSPC to a SDF-1 gradient may be modulated by both C3a and C3a des-Arg . Evidence is also provided that HSPC express a nonclassical C3a receptor that is functional with C3a des-Arg as well as with C3a. This C3a/C3a des-Arg receptor may be C5L2, as expression of C5L2 by HSPC was confirmed at the RNA level. These in vitro data, in combination with the finding of defective hematopoietic recovery ( Figure 1 ) and enhanced mobilization in vivo, 38 indicate that C3 fragment modulation of HSPC responses to a SDF-1 gradient is an important mechanism that enhances the seeding efficiency of HSPC. Up until now, no function for C3a des-Arg was known and this C3 fragment was believed to be an inactive byproduct of C activation. The current data indicate that that the short half-life of C3a is 'prolonged' by the long half-life of C3a des-Arg , and that C3a des-Arg may be recognized by HSPC via the C5L2 receptor. [6] [7] [8] Although evidence is provided that HSPC express C5L2 in addition to C3aR, a recent report was unable to show that C5L2 bound C3a or C3a des-Arg , and was only able to detect binding to C5a/ C5a des-Arg . 49 Thus, the possibility must be considered that the observed biological effects of C3a des-Arg with HSPC might be mediated by another type of C3 receptor that is yet to be identified. The possibility was also considered that the commercial source of C3a/C3a des-Arg might contain trace contamination with C5a/C5a des-Arg . However, tests showed that rC5a was unable to prime HSPC chemotactic responses to SDF-1 in the same way as did C3a/C3a des-Arg (unpublished observation). Development of C5L2-blocking antibodies or appropriate 'knockout' animals will help answer this question. Current data suggest that the priming of cells by C3a/C3a des-Arg for responses to SDF-1 occurs with what are thought to be physiologic concentrations of C3a/C3a des-Arg , and therefore may be important not only for engraftment of HSPC, but also for the trafficking of CXCR4 þ lymphocytes or monocytes/macrophages during inflammatory reactions. Thus, during the cascade of C activation, C3a/C3a des-Arg are released that function not only to chemoattract certain types of cells directly 5, 13, 16 but also to modulate/prime responses of cells to other chemoattractants indirectly (eg, SDF-1).
This report provides a molecular explanation for priming of the SDF-1-CXCR4 axis by C3a and C3a des-Arg . The data suggest ( Figure 3 ) that activation of the C5L2 (and/or other unidentified C3a-binding receptors) on hematopoietic cells facilitates the association of CXCR4 with lipid rafts, thereby promoting better SDF-1 binding and signaling. 27 Lipid raft formation is crucial for hematopoietic cell motility, as reflected by the formation of membrane ruffles and filopodia, as well as migration. These processes are regulated by small Ras-like GTPases (Rho, Rac and Cdc42) and PI3K, which can reorganize actin. 29, [31] [32] [33] The actin cytoskeleton needs to be dynamic for cell shape change, alterations in cell contact, and cell motility. 30, 34 Thus, C3a/ C3a des-Arg , by increasing the incorporation of CXCR4 into membrane lipid rafts, allows cells to interact better with several proteins that assemble in migrating cells as components of membrane lipid rafts.
With these data, a new complex picture of the mechanisms that regulate the activity of the SDF-1-CXCR4 axis is emerging. Accordingly, the functionality of CXCR4 on HSPC is modulated at different levels by several factors such as (i) level of receptor expression on the cell surface, 23 (ii) the sulfation status of its Nterminus, 55 (iii) SDF-1 availability, 25, 56, 57 (iv) cleavage of both the CXCR4 N-terminus on cells and the SDF-1 in extracellular spaces by serine proteases, 25, 26, 57, 58 (v) heterologous desensitization by the CCR5 receptor 59 and what we postulate here, (vi) modulation of CXCR4 incorporation into membrane lipid rafts for enhanced responsiveness of HSPC to a SDF-1 gradient. Thus, it may be possible to use C3a/C3a des-Arg for ex vivo priming of HSPC harvested for transplantation as a strategy to increase the responsiveness of HSPC to SDF-1, thereby improving the seeding efficiency/homing of these cells after transplantation. 18 This could be particularly important in cord blood (CB) transplants, where the number of cells available for transplantation is usually limited.
Experiments that examined the role of iC3b deposited onto BM stroma provided evidence that HSPC are tethered onto stroma cells via iC3b. Since HSPC normally express CR3, this iC3b receptor is likely to be involved in the tethering of HSPC to stroma-deposited iC3b, since the cells from CR3 À/À mice were not tethered by iC3b-coated stroma. To demonstrate this effect in vitro, it was necessary to irradiate BM stroma to produce damaged cells that activate C in subsequently added normal mouse serum. 45 Initial experiments showed that such C activation did not occur with damaged normal BM stroma and serum from SCID mice that are missing IgM natural antibodies, suggesting that irradiation damage may expose a neoepitope on The number of CFU-GM from Sca-1 + wt cells that adhered to irradiated C3 À/À stroma exposed to wt serum as a source of iC3b deposits (positive control) was arbitrarily assumed to be 100% in 1 h and 6 h adhesion assays. Data are pooled from quadruplicate samples from two independent experiments (n ¼ 8). *Po0.00001.
The role of the third complement component in engraftment of HSPC MZ Ratajczak et al BM cells that is recognized by a natural IgM antibody that functions to activate the classical pathway of C. 60 This model revealed the potential importance of the iC3b-CR3 axis in retention of HSPC on damaged stroma, and may also explain at a molecular level previous reports that anti-CR3 functioned to enhance G-CSF-mediated mobilization of HSPC in mice. 47 The potential role of C3 fragments in regulating hematopoiesis has not been recognized previously and therefore has not been taken into consideration. First, animal sera that are used for culturing cells are heat inactivated to destroy C before adding them to the culture. Second, C is not present in the so-called artificial sera that are widely used to culture/expand cells. Third, to observe the biological effect of C3 fragments, C must be activated in such a way that releases bioactive fragments such as the iC3b deposited on BM stroma.
By developing the proper tools that allow us to activate C3 in long-term cultures in vitro, we will be able to investigate if C3 fragments modulate the expansion of HSPC in a long-term culture initiating cell (LTCiC) model. Figure 5 shows our working hypothesis about how C3 fragments affect the interaction/homing of HSPC with bone marrow stroma. We postulate that, while C3a and C3a des-Arg fragments increase responsiveness of HSPC to SDF-1 gradients, iC3b tethers HSPC onto stroma cells. Thus, C activation at the site of BM injury after conditioning for transplantation functions both to release C3a/ C3a des-Arg and to deposit iC3b that targets HSPC to the areas where there is damage and regeneration/reconstitution of hematopoiesis is required. While C3a/C3a des-Arg increases responsiveness of HSPC to stroma-derived SDF-1, iC3b tethers these cells in BM microenvironment. The HSPC tethered by the iC3b-CR3 axis may also be stimulated via CR3 to interact better with the stroma cells by potentiating HSPC recognition of other lower affinity adhesion molecules.
In conclusion, new evidence has been provided that C3 fragments play an important role in the retention of HSPC in BM by (i) increasing responsiveness of HSPC to an SDF-1 gradient and (ii) by tethering HSPC on iC3b in a CR3-dependent manner. In addition, it was shown that HSPC express a second type of C3aR called C5L2, and that this receptor or perhaps another as yet to be identified receptor for C3a des-Arg is functional on HSPC. Finally, it was demonstrated that the priming HSPC responsiveness to a SDF-1 gradient could be explained at the molecular level by CXCR4 incorporation into membrane lipid rafts. CXCR4 incorporated into lipid rafts can interact better with other lipid raft-associated molecules that play an important role in chemotaxis (eg, Rac-1). 29, 31, 32 Thus, a novel interaction between the innate and acquired immune systems has been identified through which C3a/C3a des-Arg fragments may promote formation of a 'chemotactic synapse' and regulate the responsiveness of cells to chemoattractants.
Figure 5
Schematic diagram of the hypothetical role of C3 fragments in retention of HSPC in BM. C3 is activated in BM in response to marrow damage (eg, after conditioning for transplantation by TBI). Cleavage/activation of C3 secreted by BM stromal cells and macrophages is initiated by a C3-convertase to generate fluid-phase C3a and stromal cell-bound C3b. Both C3a and C3b have a short half-life. Fluid C3a is rapidly degraded to C3a des-Arg and bound C3b is proteolyzed to iC3b. We postulate that, while C3a and C3a des-Arg fragments increase responsiveness of HSPC to SDF-1 gradients, iC3b tethers HSPC onto BM stroma. The HSPC tethered by the iC3b-CR3 axis are effectively targeted to the site of injury and may interact better with stroma cells because of both CR3 signaling resulting from ligation to iC3b or enhanced recognition of lower affinity adhesion molecules.
